Palliative care in metastatic head and neck cancer.
Publication/Presentation Date
9-1-2021
Abstract
BACKGROUND: Due to inherent impact on quality of life, metastatic head and neck cancer patients are well-suited to benefit from palliative care (PC). Our objective was to examine factors that shape PC utilization and implications for overall survival in stage IVc head and neck cancer patients.
METHODS: A retrospective study of patients with stage IVc head and neck cancer in the National Cancer Database from 2004 and 2015 was conducted.
RESULTS: 7794 cases met inclusion criteria, of which 19.3% received PC. PC use was associated with more recent years of diagnosis, Northeast facility geography, and non-private insurances (p < 0.05). Compared to no PC, "interventional" PC, defined as palliative surgery, radiation, and/or chemotherapy, and "pain management only" PC were associated with lower overall survival (p < 0.05).
CONCLUSIONS: PC use increased over time and was associated with demographic and clinical factors. There remains opportunity for improvement in optimal implementation of palliative care.
Volume
43
Issue
9
First Page
2764
Last Page
2777
ISSN
1097-0347
Published In/Presented At
Civantos, A. M., Prasad, A., Carey, R. M., Bur, A. M., Mady, L. J., Brody, R. M., Rajasekaran, K., Cannady, S. B., Hartner, L., Ibrahim, S. A., Newman, J. G., & Brant, J. A. (2021). Palliative care in metastatic head and neck cancer. Head & neck, 43(9), 2764–2777. https://doi.org/10.1002/hed.26761
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
34018648
Department(s)
Administration and Leadership
Document Type
Article